Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
2.
Am J Physiol Endocrinol Metab ; 323(1): E107-E121, 2022 07 01.
Artigo em Inglês | MEDLINE | ID: mdl-35658544

RESUMO

Despite the high prevalence of obesity among middle-aged subjects, it is unclear if sex differences in middle age affect the metabolic outcomes of obesity therapies. Accordingly, in this study, middle-aged obese female and male mice were randomized to one of three groups: sleeve gastrectomy (SG), sham surgery ad libitum (SH-AL), or sham surgery with weight matching to SG through intermittent fasting with calorie restriction (SH-IF). Comprehensive measures of energy and glucose homeostasis, including energy intake, body weight, energy expenditure, glucose and insulin tolerance, and interscapular brown adipose tissue (iBAT) sympathetic innervation density were obtained. At the end of 8 wk, SG and SH-IF females had better metabolic outcomes than their male counterparts. SG females had improved weight loss maintenance, preservation of fat-free mass (FFM), higher total energy expenditure (TEE), normal locomotor activity, and reduced plasma insulin and white adipose tissue (WAT) inflammatory markers. SH-IF females also had lower plasma insulin and WAT inflammatory markers, and higher TEE than SH-IF males, despite their lower FFM. In addition, SH-IF females had higher iBAT sympathetic nerve density than SG and SH-AL females, whereas there were no differences among males. Notably, SH-IF mice of both sexes had the most improved glucose tolerance, highlighting the benefits of fasting, irrespective of weight loss. Results from this study demonstrate that in middle-aged obese mice, female sex is associated with better metabolic outcomes after SG or IF with calorie restriction. Clinical studies are needed to determine if sex differences should guide the choice of obesity therapies.NEW & NOTEWORTHY SG or IF with calorie restriction produces better metabolic outcomes in females than in males. IF with calorie restriction prevents metabolic adaptation, even in the face of fat-free mass loss. IF with calorie restriction in females only, is associated with increased iBAT sympathetic innervation, which possibly mitigates reductions in energy expenditure secondary to fat-free mass loss. Lastly, IF leads to better glucose homeostasis than SG, irrespective of sex.


Assuntos
Jejum , Insulinas , Animais , Feminino , Humanos , Masculino , Camundongos , Gastrectomia/métodos , Glucose/metabolismo , Camundongos Obesos , Obesidade/metabolismo , Obesidade/cirurgia , Caracteres Sexuais , Redução de Peso/fisiologia
3.
Diabetes Obes Metab ; 21(2): 377-381, 2019 02.
Artigo em Inglês | MEDLINE | ID: mdl-30101510

RESUMO

Data suggest that nutrient order during a meal significantly impacts postprandial glucose and insulin excursions in type 2 diabetes, while its effects in prediabetes have not been reported. Fifteen participants with prediabetes consumed the same meal on 3 days in random order: carbohydrate first, followed 10 minutes later by protein and vegetables (CF); protein and vegetables first, followed 10 minutes later by carbohydrate (PVF); or vegetables first followed by protein and carbohydrate (VF). Blood was sampled for glucose and insulin measurements at 0, 30, 60, 90, 120, 150 and 180 minutes. Incremental glucose peaks were similarly attenuated by >40% in the PVF and VF meal conditions compared with CF. The incremental area under the curve for glucose was 38.8% lower following the PVF meal order, compared with CF, and postprandial insulin excursions were significantly lower in the VF meal condition compared with CF. The CF meal pattern showed marked glycaemic variability whereas glucose levels were stable in the PVF and VF meal conditions. Food order presents a novel, simple behavioural strategy to reduce glycaemic excursions in prediabetes.


Assuntos
Glicemia/metabolismo , Comportamento Alimentar/fisiologia , Hiperglicemia/etiologia , Refeições/fisiologia , Estado Pré-Diabético/sangue , Adulto , Idoso , Estudos Cross-Over , Feminino , Humanos , Hiperglicemia/sangue , Insulina/sangue , Masculino , Pessoa de Meia-Idade , Período Pós-Prandial , Estado Pré-Diabético/complicações , Estudos Retrospectivos
5.
Nature ; 549(7670): 48-53, 2017 09 07.
Artigo em Inglês | MEDLINE | ID: mdl-28854168

RESUMO

Commensal bacteria are believed to have important roles in human health. The mechanisms by which they affect mammalian physiology remain poorly understood, but bacterial metabolites are likely to be key components of host interactions. Here we use bioinformatics and synthetic biology to mine the human microbiota for N-acyl amides that interact with G-protein-coupled receptors (GPCRs). We found that N-acyl amide synthase genes are enriched in gastrointestinal bacteria and the lipids that they encode interact with GPCRs that regulate gastrointestinal tract physiology. Mouse and cell-based models demonstrate that commensal GPR119 agonists regulate metabolic hormones and glucose homeostasis as efficiently as human ligands, although future studies are needed to define their potential physiological role in humans. Our results suggest that chemical mimicry of eukaryotic signalling molecules may be common among commensal bacteria and that manipulation of microbiota genes encoding metabolites that elicit host cellular responses represents a possible small-molecule therapeutic modality (microbiome-biosynthetic gene therapy).


Assuntos
Amidas/metabolismo , Bactérias/metabolismo , Mimetismo Biológico , Trato Gastrointestinal/microbiologia , Receptores Acoplados a Proteínas G/metabolismo , Transdução de Sinais , Simbiose , Amidas/química , Animais , Bactérias/enzimologia , Bactérias/genética , Glicemia/metabolismo , Feminino , Microbioma Gastrointestinal/genética , Microbioma Gastrointestinal/fisiologia , Trato Gastrointestinal/metabolismo , Células HEK293 , Homeostase , Humanos , Ligantes , Masculino , Camundongos
6.
J Clin Endocrinol Metab ; 95(5): 2227-33, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20335447

RESUMO

CONTEXT: The thionamide antithyroid drugs methimazole and propylthiouracil are the mainstay of pharmacologic therapy for Graves' disease. However, little is known about the rate of use of these drugs and the prescribing practices of physicians treating hyperthyroidism. OBJECTIVE: The objective of the study was to examine the frequency of methimazole and propylthiouracil use from years 1991 to 2008. METHODS: The data were acquired by the U.S. Food and Drug Administration's Division of Epidemiology through two databases: IMS National Sales Perspectives and the Surveillance Data, Inc. Vector One: National database. RESULTS: There was a 9-fold increase in the annual number of methimazole prescriptions during the study period, from 158,000 to 1.36 million per year. There was a 19% increase in the annual number of propylthiouracil prescriptions, from 348,000 to 415,000 per year. Propylthiouracil, which held two thirds of the market from 1991 to 1995, was surpassed by methimazole in 1996. Patient demographic data indicated that although 72% of methimazole prescriptions were for females, males were more likely to be on methimazole (82%) than females (74%) (P < 0.001, two tailed chi(2) test). The only demographic group in which methimazole use decreased was women of child-bearing age (5% decrease, P < 0.001, two tailed chi(2)). The incidence of hyperthyroidism in 2008 was estimated based on the number of new prescriptions of thionamides by age group and data from the 2008 U.S. census: 0.44 per 1000 for ages 0-11 yr, 0.26 per 1000 for ages 12-17 yr, 0.59 per 1000 for ages 18-44 yr, 0.78 per 1000 for ages 45-64 yr, and 1.01 per 1000 for ages 65+ yr. CONCLUSIONS: Methimazole has become the most frequently prescribed antithyroid drug. The remarkable increase in the total number of dispensed thionamide prescriptions over the last 18 yr may indicate a trend toward pharmacological treatment as primary treatment of Graves' disease in the United States.


Assuntos
Antitireóideos/uso terapêutico , Prescrições de Medicamentos/estatística & dados numéricos , Metimazol/uso terapêutico , Medicamentos sob Prescrição/uso terapêutico , Propiltiouracila/uso terapêutico , Adolescente , Adulto , Fatores Etários , Idoso , Criança , Pré-Escolar , Feminino , Humanos , Hipertireoidismo/tratamento farmacológico , Hipertireoidismo/epidemiologia , Incidência , Masculino , Pessoa de Meia-Idade , Caracteres Sexuais , Estados Unidos/epidemiologia , United States Food and Drug Administration
7.
Neuropsychopharmacology ; 32(5): 977-88, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17035935

RESUMO

Oxytocin (OT) is a neuropeptide synthesized in the paraventricular (PVN) and supraoptic nuclei (SON) in the hypothalamus. Although OT is more commonly known for its role in the milk-ejection reflex, in recent years research has indicated that OT participates in the expression of social behavior, memory processing, modulation of fear, and stress responses. The demonstration that OT influences affiliative behaviors, such as parental care and reproduction, and decreases anxiety has lead to speculations that it may have a role in mood disorders. Evidence from pharmacologic studies, pointing out the modulation of the OT system by serotonin, has argued in favor of OT as a mediator of serotonin reuptake inhibitors (SSRIs) antidepressant properties. In the present study, we investigated the distribution and overlap of OT-labeled cells and serotonin transporter (5-HTT) immunoreactive (IR) fibers in the Macaque hypothalamus, utilizing immunocytochemical and double-immunofluorescent techniques. Consistent with previous reports, the distribution of OT-labeled cells in the hypothalamus is confined to the PVN and SON. In these nuclei, we demonstrate that the distribution of 5-HTT-labeled fibers follows the distribution of OT-labeled cells. Overlap of OT-labeled neurons and 5-HTT-IR fibers occurs in the parvicellular, magnocellular, dorsal, and posterior subdivisions of the PVN. In the SON, 5-HTT-labeled fibers and OT-labeled cells overlap in the ventromedial subdivision and in the 'capsular' part of the dorsolateral SON. These findings provide neuroanatomic support for the idea that SSRIs' therapeutic effects on social affiliation and anxiety may be mediated in part through components of the OT system.


Assuntos
Hipotálamo/metabolismo , Vias Neurais/metabolismo , Neurônios/metabolismo , Ocitocina/metabolismo , Inibidores Seletivos de Recaptação de Serotonina/farmacologia , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Animais , Transtornos de Ansiedade/tratamento farmacológico , Transtornos de Ansiedade/metabolismo , Transtornos de Ansiedade/fisiopatologia , Axônios/efeitos dos fármacos , Axônios/metabolismo , Comportamento Animal/fisiologia , Mapeamento Encefálico , Feminino , Hipotálamo/anatomia & histologia , Hipotálamo/efeitos dos fármacos , Imuno-Histoquímica , Macaca fascicularis , Macaca nemestrina , Masculino , Comportamento Materno/fisiologia , Vias Neurais/efeitos dos fármacos , Neurônios/citologia , Neurônios/efeitos dos fármacos , Serotonina/metabolismo , Comportamento Social , Transtornos do Comportamento Social/tratamento farmacológico , Transtornos do Comportamento Social/metabolismo , Transtornos do Comportamento Social/fisiopatologia , Especificidade da Espécie
8.
Neuropsychopharmacology ; 29(5): 833-46, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-14997175

RESUMO

The widespread use of the selective serotonin reuptake inhibitors (SSRIs) has been accompanied by numerous reports describing a potential association with hyperprolactinemia. Antipsychotics are commonly known to elevate serum prolactin (PRL) through blockade of dopamine receptors in the pituitary. However, there is little awareness of the mechanisms by which SSRIs stimulate PRL release. Hyperprolactinemia may result in overt symptoms such as galactorrhea, which may be accompanied by impaired fertility. Long-term clinical sequelae include decreased bone density and the possibility of an increased risk of breast cancer. Through literature review, we explore the possible pathways involved in serotonin-induced PRL release. While the classic mechanism of antipsychotic-induced hyperprolactinemia directly involves dopamine cells in the tuberoinfundibular pathway, SSRIs may act on this system indirectly through GABAergic neurons. Alternate pathways involve serotonin stimulation of vasoactive intestinal peptide (VIP) and oxytocin (OT) release. We conclude with a comprehensive review of clinical sequelae associated with hyperprolactinemia, and the potential role of SSRIs in this phenomenon.


Assuntos
Doenças Ósseas Metabólicas/induzido quimicamente , Galactorreia/induzido quimicamente , Hiperprolactinemia/induzido quimicamente , Inibidores Seletivos de Recaptação de Serotonina/efeitos adversos , Serotonina/fisiologia , Animais , Feminino , Humanos , Hiperprolactinemia/fisiopatologia , Hipotálamo/efeitos dos fármacos , Hipotálamo/metabolismo , Hipófise/efeitos dos fármacos , Hipófise/metabolismo , Fatores de Risco
9.
J Neuropsychiatry Clin Neurosci ; 15(3): 306-16, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-12928506

RESUMO

The dopamine (DA) system has long been associated with the pathophysiology of psychosis. The DA theory of schizophrenia continues to find support in neuroreceptor imaging and ligand-binding studies that show excess DA transmission in patients, as compared to controls. The pathways that regulate the primate DA system, however, have yet to be fully elucidated. The amygdala, including its extended amygdala component, is involved in evaluating the emotional value of sensory stimuli. Since emotionally relevant sensory stimuli are distorted during psychotic episodes, we hypothesize that amygdaloid influences are likely to be significant modulators of the DA system. We reviewed evidence for direct projections from the central extended amygdala to specific subpopulations of DA neurons, and we discuss how these pathways may serve as important conduits of emotionally relevant information that can have immediate and long-term effects on DA regulation.


Assuntos
Tonsila do Cerebelo/fisiologia , Dopamina/fisiologia , Tonsila do Cerebelo/anatomia & histologia , Animais , Transtornos da Percepção Auditiva/metabolismo , Humanos , Vias Neurais/anatomia & histologia , Vias Neurais/fisiologia , Neurônios/metabolismo , Substância Negra/anatomia & histologia , Substância Negra/metabolismo , Tirosina 3-Mono-Oxigenase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA